3.2.S.4.3 Contains the validation of analytical procedures including: 包含分析方法的方法验证 (1) full validation reports for in-house methods and their equivalence to United States Pharmacopeia (USP) procedures if available for the drug substan...
3.2.S.4.3 Contains the validation of analytical procedures including: 包含分析方法的方法验证 full validation reports for in-house methods and their equivalence to United States Pharmacopeia procedures if available for the drug substance; 内控方法的全验证 verification of USP <1226> or DMF procedures, ...
3.2.S.4.3 Contains the validation of analytical procedures including: 包含分析方法的方法验证 (1) full validation reports for in-house methods and their equivalence to United States Pharmacopeia (USP) procedures if available for the drug substance; 内控方法的全验证 (2) verification of USP <1226> ...
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。 5. 装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
Full NameCTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 Calculated Molecular Weight29 kDa Observed Molecular Weight29-33 kDa GenBank Accession NumberBC012977 Gene SymbolCTDSP1 Gene ID (NCBI)58190 RRIDAB_2087073 ...
关于新药注册申请提交CTD格式资料要求 (英文版)2. 3. P DRUG PRODUCT (NAME, DOSAGE FORM)2.3.P.1 Description and Composition of the Drug Product （1）A description of the dosage of drug product and its composition should be provided with a table to present the action of each composition and...
Journal Impact FactorMost recent Human Mouse Rat Monkey Pig SpeciesApplicationTitle humanWB J Biol Chem Phosphatase activity of Small C-terminal domain phosphatase 1 (SCP1) controls the stability of the key neuronal regulator RE1-silencing transcription factor (REST)....
2.5 (Page: ) for the details.2.3.P.3 Manufacture2.3.P.3.1 ManufacturesThe name (full name), address, telephone number and fax of each manufacturer and each proposed production site or facility involved in manufacturing and testing should be provided.2.3.P.3.2 batch formul 16、aA description ...
2.3.P.3 Manufacture 2.3.P.3.1 Manufactures The name (full name), address, telephone number and fax of each manufacturer and each proposed production site or facility involved in manufacturing and testing should be provided. 3 2.3.P.3.2 batch formula A description of the composition of drug ...
The electronic form of this marketing authorisation document, known as an eCTD, contains the same information found in a regular CTD. The individual modules are saved as XML documents in a specific file structure. Supplementary information is then added, and the entire documentation is transmitted ...